Grants
Grants
Overview
Our experts have been highly successful in attracting important infrastructure and research grants, around Australia and across the world, leading to numerous collaborative projects and bioinformatics tools.
Active
Melbourne Bioinformatics researchers highlighted in bold.
| Investigators | Project | Funding source | Amount | Start | End |
|---|---|---|---|---|---|
| Olivia Carter, Malcolm McConville, David Stroud, Daniella Hock, Richard Saffery, Bernard Pope, Julian Simmons, Sammy Bedoui, Stuart Dashper, Kaylene Simpson, John Christodoulou, Mihiri Silva, Benjamin Parker, Kim-Anh Le Cao, Michael Menden | OMIX3: High-capacity integrated multi-omics | MRFF, Thermo Fisher Scientific, Bioplatforms Australia, Australian BioCommons, University of Melbourne | $15.83M | 2024 | 2028 |
| Niall Corcoran, Chris Hovens, Bernard Pope, Tony Papenfuss, Lih-Ming Wong, Nathan Lawrentschuk, Sibel Saya, Dennis Gyomber | GenI-AIRSPACE: Genomically Informed Active Surveillance in Intermediate Risk Prostate Cancer | The Advanced Genomics Collaboration (TAGC) | $2M | 2024 | 2026 |
| William Heath, Lynette Beattie, Luke Gandolfo | The role of IL-4 as a key regulator of CD8 T cell response development | ARC | $1.4M | 2026 | 2029 |
| Daniel Park | Melbourne Bioinformatics Workshop Trainer Program for Graduate Researchers/Students | University of Melbourne Faculty of Medicine, Health Sciences and Dentistry | $15K | 2024 | 2024 |
| Bernard Pope, Andrew Gilbert, Andrew Lonie, Jessica Holliday | Genomics uplift for Australia through research data infrastructure at national scale (GUARDIANS) | NCRIS | $25M | 2024 | 2028 |
| Peter AW Rogers, Jacqueline Donoghue, Wan Tinn Teh, Jessica Chung, Martin Healey, Samantha Mooney | Improving women's health outcomes through genomics | The Advanced Genomics Collaboration (TAGC) | $2M | 2024 | 2026 |
| Peter Meikle, Gemma Figtree, Andrew Lonie, Bernard Pope , Andrew Gilbert, Clare Bernard, Ashok Krishnamurthy, Dianna Magliano, Guy Krippner, Jean Yang, Anthony Keech, Steven Manos, Rhys Francis, Angela Webster and Robert Grossman | Building an Australian cardiovascular disease data commons | MRFF, Bioplatforms Australia | $5.5M | 2023 | 2027 |
| Anne-Louise Ponsonby, Jeannette Lechner-Scott, Steve Simpson-Yap, Daniel Park, Dominic Dwyer, Ingrid van der Mei, Tomas Kalincik, Trevor Kilpatrick, Amit Bar-Or | Understanding how Epstein-Barr virus and other factors program multiple sclerosis onset and progression through epigenetic pathways to inform prevention and treatment with risk stratification | MRFF | $1.8M | 2023 | 2027 |
Completed
Melbourne Bioinformatics researchers highlighted in bold.
| Investigators | Project | Funding source | Amount | Start | End |
|---|---|---|---|---|---|
| Christopher Hovens, Kate Drummond, Niall Corcoran, Bernard Pope and Stan Stylli | The Genetic Drivers of Brain Metastases | CASS Foundation | $65k | 2022 | 2023 |
| Anis Hamid, Ian Davis, Christopher Sweeney, Arun Azad, Ben Tran, Shahneen Sandhu, Chris Hovens, Niall Corcoran, Bernie Pope, Chol-Hee Jung and Yi Sun | MEMENTO: Biomarker discovery in metastatic hormone sensitive prostate cancer | Below The Belt Research Fund, Australia and New Zealand Urogenital and Prostate Cancer Trials Group | $50k | 2021 | 2023 |
| Khalid Mahmood, Ingrid Winship, Daniel Buchanan, Peter Georgeson, Emma Barrance, Natalie Diepenhorst and Julie Toner | What can tumour mutational signatures tell us about the cause of familial colorectal cancer? | Cancer Council Victoria | $200k | 2021 | 2023 |
| Niall Corcoran, Paul Boutros, Robert Bristow, Margaret Centenera, Ian Collins, Rosalind Eeles, Vanessa Hayes, Chris Hovens, Maarten ljzerman, Anthony Papenfuss, Belinda Parker, Daniel Park, Bernard Pope, Chris Sweeney and Ben Tran | PRECEPT – Prostate Cancer Prognosis and Treatment | MRFF and Movember Foundation | $5.3M | 2019 | 2023 |
| Andrew Lonie | Australian BioCommons | NCRIS via Bioplatforms Australia | $20M | 2019 | 2023 |
| Christopher Hovens, Niall Corcoran, Daniel Park and Anthony Costello | The genomic drivers of high risk prostate cancer | NHMRC | $595k | 2019 | 2022 |
| Bernard Pope | Translating genomics-driven bioinformatics into improved prevention and treatment of colorectal cancer | Victorian Health and Medical Research Fellowship, Department of Health and Human Services, Victoria | $800k | 2017 | 2022 |
| Jeremy Goecks, Nuwan Goonasekera and Enis Afgan | Extending Galaxy for Large-scale and Integrative Biomedical Analyses | Chan Zuckerberg Initiative | $190k USD | 2021 | 2021 |
| Tim Stinear, Christopher Mcdevitt and Torsten Seemann | Essential gene regulation in multi-drug resistant Golden Staph: a new path towards control | NHMRC | $795k | 2018 | 2021 |
| Tim Stinear and Torsten Seemann | Understanding virulence of invasive Staphylococcus aureus | NHMRC | $784k | 2018 | 2020 |
| Bernard Pope | Using structural homology prediction to improve functional annotation of biologically important proteomes | Amazon AWS Cloud Credits for Research Program | $20k USD | 2017 | 2017 |
| Daniel Buchanan, Ingrid Winship, Amanda Spurdle, Aung Ko Win, Bernard Pope , Christophe Rosty and Finlay Macrae | Expanding diagnostic approaches for Lynch syndrome | NHMRC | $1.3M | 2017 | 2020 |
| Justin Zobel, Michael Parker, Andrew Ooi, Richard Sandberg, Andrew Lonie , Salvy Russo, Toby Allen, Irene Yarovsky, Tiffany Walsh, John Grundy, Maria Forsyth and Brian Smith | A high-performance cloud resource for computational modelling | ARC | $635k | 2017 | 2017 |
| Peter Cowan et al (including Matthew Wakefield ) | Genetic modification to protect pig islets from T cell-mediated xenogeneic rejection | JRDF | $675k | 2017 | 2020 |
| Benjamin Howden, Martyn Kirk, Deborah Williamson, Torsten Seemann and Nigel French |
A new genomic frontier for foodborne disease investigation | NHMRC | $751k | 2017 | 2020 |
| Kathryn North et al (including Andrew Lonie ) | Preparing Australia for genomic medicine: a proposal by the Australian Genomics Health Alliance | MRFF | $25M | 2016 | 2021 |
| Martyn Kirk, Dieter Bulach and Kathryn Glass | Understanding the sources of Campylobacter in Australia | NHMRC | $558k | 2016 | 2019 |
| Dieter Bulach, David McCarthy, Darren Cottam, Michèle Gourmelon and Toby Prosser | Safe to swim with the bugs? From hazard identification to risk management | ARC | $435k | 2016 | 2020 |
| Tim Stinear, Benjamin Howden, Sacha Pidot and Torsten Seemann | New antibiotics from old microbes | NHMRC | $1.04M | 2016 | 2019 |
| Daniel Park and Daniel Buchanan | A functional assay to classify genetic variants in Lynch syndrome | NHMRC | $376k | 2016 | 2017 |
| Torsten Seemann, Benjamin Howden, Tim Stinear and Paul Johnson | Dissecting the molecular basis for emerging alcohol tolerance in VRE | NHMRC | $837k | 2015 | 2018 |
| John Heath, Melissa Southey, John Hopper, Andrew Lonie , Daniel Park , Tu Nguyen-Dumont, Gillian Dite and Bernard Pope | High risk genes for childhood cancer: using massively parallel sequencing to identify cancer susceptibility | Cancer Australia | $200k | 2014 | 2017 |
| Daniel Park, David Goldgar, Bernard Pope , Tu Nguyen-Dumont and Andrew Lonie | Mouse phenotype-driven breast cancer risk gene discovery | Cancer Council Victoria | $200k | 2014 | 2015 |
| Daniel Park, Leonie Quinn, Melissa Southey, Tim Stinear and Graham Taylor | Multi-sample DNA shearing system | Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne | $11k | 2014 | 2014 |
| Daniel Park and Bernard Pope | Massively parallel sequencing and PCR optimised for DNA-based diagnosis and discovery | NHMRC | $197k | 2012 | 2013 |